Checked
Psoriasis Clinical Trials in South Carolina
Open studies with at least one site in the state
Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.
- Open studies
- 3
- With a site in South Carolina
- Most studies in
- Charleston
- 1 of the studies shown
Studies
3 of 3, recruiting studies first. Cities are where the study lists a South Carolina site.
- Observational Study of Pediatric Rheumatic Diseases: The CARRA RegistryRecruitingNCT02418442· Duke University
Charleston
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)RecruitingPhase 4NCT06857942· Eli Lilly and Company
Columbia
- A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsRecruitingPhase 1NCT07290036· UCB Biopharma SRL
Rock Hill
Other other conditions studies in South Carolina
Frequently asked questions
- Are there psoriasis clinical trials in South Carolina?
- Yes. 3 psoriasis studies on ClinicalTrials.gov list at least one site in South Carolina and are recruiting, about to recruit or enrolling by invitation, including sites in Charleston, Columbia, Rock Hill.
- What does recruiting mean?
- Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
- How do I join a clinical trial?
- Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.
Source: ClinicalTrials.gov, National Library of Medicine · Last updated 10/26/2026